Nurse Practitioner, Family · Springfield, MA
NPI
1013517887
Since 2020
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1049 Main St
Springfield, MA, 01103
Phone (413) 739-1100
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$642K
6,933 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Karina Kovalevich prescribed most often to Medicare patients was Atorvastatin Calcium, with 423 prescriptions and refills. In total Karina Kovalevich wrote 6,933 Medicare prescriptions that cost $642K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 423 | 444 | 69 | $4,732 |
| Amlodipine Besylate Generic | 409 | 416 | 57 | $3,234 |
| Rosuvastatin Calcium Generic | 283 | 292 | 34 | $4,104 |
| Metoprolol Succinate Generic | 273 | 276 | 37 | $4,765 |
| Lisinopril Generic | 218 | 225 | 28 | $2,026 |
| Diclofenac Sodium Generic | 204 | 204 | 64 | $12K |
| Furosemide Generic | 198 | 199 | 29 | $2,031 |
| Omeprazole Generic | 170 | 173 | 28 | $1,907 |
| Gabapentin Generic | 136 | 137 | 26 | $1,909 |
| Losartan Potassium Generic | 127 | 130 | 21 | $1,620 |
| Tamsulosin Hcl Generic | 124 | 133 | 21 | $1,766 |
| Metformin Hcl Er Metformin Hcl | 117 | 118 | 17 | $1,322 |
| Januvia Sitagliptin Phosphate | 115 | 115 | 11 | $64K |
| Alendronate Sodium Generic | 104 | 108 | 20 | $1,040 |
| Valsartan Generic | 103 | 103 | 11 | $2,893 |
Brand drugs: 980 claims; generic drugs: 5,897 claims; opioid claims: 73.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Karina Kovalevich were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.